ArticleCureus2026
Cystic Clival Chordoma Presenting With Cerebrospinal Fluid Rhinorrhea: A Case Report and Literature Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chordomas are rare malignant tumors that typically arise at the skull base and rarely present with cerebrospinal fluid (CSF) rhinorrhea. We report the case of a 40-year-old man with a clival chordoma who initially presented with headaches and serous rhinorrhea. Imaging revealed a non-enhancing cystic lesion extending from the prepontine cistern to the sphenoid sinus. Endoscopic endonasal removal of the cystic lesion and dural reconstruction was performed. Histopathology of the lesion confirmed a conventional chordoma, with positive brachyury and preserved nuclear SMARCB1 staining. The diagnosis was based on the surgical findings and histological analysis, including the Ki-67 labeling index and bone invasion. The patient recovered uneventfully and has remained free of both tumor recurrence and CSF rhinorrhea for more than two years. This case highlights the importance of including chordomas in the differential diagnosis of CSF rhinorrhea due to clival cystic lesions. It also emphasizes the critical role of histopathological examination in distinguishing chordomas from other clival lesions, such as ecchordosis physaliphora (EP). Gross total resection (GTR) should be performed when feasible, and histologic evidence of bone invasion can be an important diagnostic clue for chordomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.